Medscape2h
High-Dose Vitamin D Curbs Disease Activity in Early Multiple Sclerosis
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
Nasal Polyps Treatment Market Set To Surge To $4.24 Billion By 2030 At A 5.6% CAGR
Nasal Polyps Treatment Market Research Report The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030 ...
Investing News Network on MSN12h
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
Medscape25m
Trial Shows Dupilumab Reduces Itch, Disease Activity, Steroid Use in Bullous Pemphigoid
Dupilumab had a fivefold improvement in sustained disease remission in bullous pemphigoid compared with placebo, along with a significant reduction in oral corticosteroid use.
7 European Stocks to Buy Now
The following seven leading European stocks all offer significant scale, along with insulation from U.S. market volatility ...
Hemophilia Market Size to Hit USD 24.2 Billion by 2032, Driven by Advancements in Gene Therapy and Innovative Treatment Solutions – SNS Insider
Rising Prevalence of Hemophilia, Increasing Adoption of Recombinant Therapies, and Breakthroughs in Gene Therapy Propel Market Growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Size & ...
Taiwan News13h
Global Hemophilia Treatment Market to Reach USD 21.48 Billion by 2033, Driven by Advanced Therapies and Innovative Solutions
Market Valuation Set to Surge from USD 13.23 Billion in 2024 at a CAGR of 5.69% ...
Indiatimes12h
Sanofi India Share Price
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,624.35 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...